Superficial high-dose-rate brachytherapy for primary tumors and relapses after surgery in patients with basal cell carcinoma of the head and neck region: results of a retrospective comparative cohort study.

J Contemp Brachytherapy · 2022 · PMC9720694 · PMID 36478698

Europe PMC DOI

hedged sentence

0.1600

closest p · 3.2× alpha

0.1600

boldest claim

The sentences

did not reach statistical significancep = 0.16not close (p > 0.1)

Additionally, the differences between the frequency of late complications degrees did not reach statistical significance ( p = 0.16) despite the apparent difference in the occurrence of G4 toxicity between the groups.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.